Blue water vaccines announces expanded license agreement with st. jude children's research hospital for novel bacterial vaccine platform

Cincinnati, may 11, 2022 (globe newswire) -- blue water vaccines inc. (“bwv” or “blue water vaccines” or “the company”), a biopharmaceutical company developing transformational vaccines, today announced an expanded license agreement has been signed with st. jude children's research hospital (“st. jude”). through research funded by blue water vaccines, st. jude designed genetic constructs to express bacterial proteins on the surface of streptococcus pneumoniae.
BWV Ratings Summary
BWV Quant Ranking